130 related articles for article (PubMed ID: 29522253)
21. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
Song S; Chen JK; He ML; Fotherby K
Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034
[TBL] [Abstract][Full Text] [Related]
22. The JAK1 Inhibitor Upadacitinib Has No Effect on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol: A Study in Healthy Female Subjects.
Mohamed MF; Trueman S; Feng T; Friedman A; Othman AA
J Clin Pharmacol; 2019 Apr; 59(4):510-516. PubMed ID: 30500075
[TBL] [Abstract][Full Text] [Related]
23. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.
Endrikat J; Hite R; Bannemerschult R; Gerlinger C; Schmidt W
Contraception; 2001 Jul; 64(1):3-10. PubMed ID: 11535206
[TBL] [Abstract][Full Text] [Related]
24. Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive.
Yu Z; Yu D; Walker PS; Tang-Liu DD
Clin Pharmacokinet; 2004; 43(10):673-84. PubMed ID: 15244497
[TBL] [Abstract][Full Text] [Related]
25. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
Sinofsky FE; Pasquale SA
Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
[TBL] [Abstract][Full Text] [Related]
26. Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive.
Reyes M; Brossard P; Chassard D; Hoch M; Dingemanse J
Eur J Clin Pharmacol; 2014 Mar; 70(3):287-93. PubMed ID: 24362488
[TBL] [Abstract][Full Text] [Related]
27. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
[TBL] [Abstract][Full Text] [Related]
28. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
29. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
30. Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteers.
Crauwels HM; van Heeswijk RP; Buelens A; Stevens M; Hoetelmans RM
Int J Clin Pharmacol Ther; 2014 Feb; 52(2):118-28. PubMed ID: 24161160
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
David OJ; Ocwieja M; Meiser K; Emotte C; Jakab A; Wemer J; den Daas I; Schmouder R
Int J Clin Pharmacol Ther; 2012 Aug; 50(8):540-4. PubMed ID: 22735460
[TBL] [Abstract][Full Text] [Related]
32. The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir.
Garg V; van Heeswijk R; Yang Y; Kauffman R; Smith F; Adda N
J Clin Pharmacol; 2012 Oct; 52(10):1574-83. PubMed ID: 22039291
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
Carol W; Klinger G; Jäger R; Kasch R; Brandstädt A
Exp Clin Endocrinol; 1992; 99(1):12-7. PubMed ID: 1628691
[TBL] [Abstract][Full Text] [Related]
34. The interaction between St John's wort and an oral contraceptive.
Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
[TBL] [Abstract][Full Text] [Related]
35. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
36. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
[TBL] [Abstract][Full Text] [Related]
37. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR
Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
[TBL] [Abstract][Full Text] [Related]
38. Metabolic effects of combined oral contraceptive preparations.
Singh BM; Nutter SA; Nattrass M
Contraception; 1987 Dec; 36(6):651-8. PubMed ID: 3128428
[TBL] [Abstract][Full Text] [Related]
39. Contraception with progestagens in systemic lupus erythematosus.
Mintz G; Gutiérrez G; Delezé M; Rodríguez E
Contraception; 1984 Jul; 30(1):29-38. PubMed ID: 6434228
[TBL] [Abstract][Full Text] [Related]
40. Norethisterone levels in maternal serum and milk after intramuscular injection of norethisterone oenanthate as a contraceptive.
Fotherby K; Towobola O; Muggeridge J; Elder MG
Contraception; 1983 Nov; 28(5):405-11. PubMed ID: 6673900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
